2024
Torsemide vs Furosemide Among Patients With New-Onset vs Worsening Chronic Heart Failure
Krim S, Anand S, Greene S, Chen A, Wojdyla D, Vilaro J, Haught H, Herre J, Eisenstein E, Anstrom K, Pitt B, Velazquez E, Mentz R. Torsemide vs Furosemide Among Patients With New-Onset vs Worsening Chronic Heart Failure. JAMA Cardiology 2024, 9: 182-188. PMID: 37955908, PMCID: PMC10644243, DOI: 10.1001/jamacardio.2023.4776.Peer-Reviewed Original ResearchDe novo heart failureNovo heart failureChronic heart failureHeart failurePatient-reported outcomesCause mortalityHF typeKansas City Cardiomyopathy Questionnaire clinical summary scoreHigher glomerular filtration rateSignificant differencesHeart Failure TrialGlomerular filtration rateClinical summary scoreDiuretic strategyFirst rehospitalizationCause hospitalizationNew onsetTotal hospitalizationsClinical characteristicsClinical profileEjection fractionLoop diureticsFailure TrialHospitalization outcomesNatriuretic peptide
2023
Radiographic Signs of Advanced Cerebral Venous Thrombosis Negatively Modulate the Effectiveness of Endovascular Treatments
Chen H, Khunte M, Colasurdo M, Singh P, Malhotra A, Gandhi D. Radiographic Signs of Advanced Cerebral Venous Thrombosis Negatively Modulate the Effectiveness of Endovascular Treatments. Cerebrovascular Diseases 2023, 53: 519-526. PMID: 37931607, DOI: 10.1159/000534821.Peer-Reviewed Original ResearchCerebral venous thrombosisGood discharge outcomeEndovascular treatmentRadiographic signsCVT patientsHospital mortalityVenous thrombosisDischarge outcomesMedical managementBetter outcomesSevere cerebral venous thrombosisNational Inpatient Sample databaseConservative medical managementPatient selection practicesPresence of infarctionShort-term effectivenessEVT patientsEVT treatmentParenchymal manifestationsMedical comorbiditiesMultivariable adjustmentCerebral infarctionPatient demographicsSecondary outcomesHospitalization outcomes
2021
681 Sleep Apnea Severity and COVID-19 Hospitalization Outcomes: Interim Analysis
Mansour W, Knauert M. 681 Sleep Apnea Severity and COVID-19 Hospitalization Outcomes: Interim Analysis. Sleep 2021, 44: a266-a266. PMCID: PMC8135644, DOI: 10.1093/sleep/zsab072.679.Peer-Reviewed Original ResearchModerate-severe OSA groupCOVID-19 illnessComposite outcomeSleep apneaMild diseaseInterim analysisCritical illnessHospitalization outcomesOSA groupRisk factorsMortality rateRetrospective electronic medical chart reviewElectronic medical chart reviewModerate-severe diseaseSevere sleep apneaMedical chart reviewOverall mortality rateSleep apnea severityCOVID-19 comorbiditiesCommon risk factorsLogistic regression analysisHigh mortality rateSignificant differencesMedian LOSSevere OSA
2018
Emergency department boarding and adverse hospitalization outcomes among patients admitted to a general medical service
Lord K, Parwani V, Ulrich A, Finn EB, Rothenberg C, Emerson B, Rosenberg A, Venkatesh AK. Emergency department boarding and adverse hospitalization outcomes among patients admitted to a general medical service. The American Journal Of Emergency Medicine 2018, 36: 1246-1248. PMID: 29605480, DOI: 10.1016/j.ajem.2018.03.043.Peer-Reviewed Original ResearchConceptsAdverse hospitalization outcomesRapid response team activationGeneral medical servicesHospitalization outcomesEmergency departmentED boardingComposite outcomeCare escalationPrimary outcomeAdverse outcomesRRT activationPatient encountersConsecutive patient encountersGeneral medicine serviceInpatient hospital stayMedical servicesEmergency department boardingED departureHospital mortalityHospital deathHospital stayED admissionPatient demographicsHospital admissionIntensive care
2017
Seasonal variation in hospitalization outcomes in patients admitted for heart failure in the United States
Akintoye E, Briasoulis A, Egbe A, Adegbala O, Alliu S, Sheikh M, Singh M, Ahmed A, Mallikethi‐Reddy S, Levine D. Seasonal variation in hospitalization outcomes in patients admitted for heart failure in the United States. Clinical Cardiology 2017, 40: 1105-1111. PMID: 28873233, PMCID: PMC6490330, DOI: 10.1002/clc.22784.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultAge FactorsAgedAged, 80 and overChi-Square DistributionDatabases, FactualFemaleHeart FailureHospital CostsHospital MortalityHumansIncidenceLength of StayLogistic ModelsMaleMiddle AgedMultivariate AnalysisOdds RatioPatient AdmissionPrevalenceRisk FactorsSeasonsSex FactorsTime FactorsUnited StatesYoung AdultEffect of Hospital Ownership on Outcomes of Heart Failure Hospitalization
Akintoye E, Briasoulis A, Egbe A, Orhurhu V, Ibrahim W, Kumar K, Alliu S, Nas H, Levine D, Weinberger J. Effect of Hospital Ownership on Outcomes of Heart Failure Hospitalization. The American Journal Of Cardiology 2017, 120: 831-837. PMID: 28689752, DOI: 10.1016/j.amjcard.2017.06.009.Peer-Reviewed Original ResearchConceptsInpatient mortalityFemale patientsGovernment hospitalsHospitalization outcomesHospital ownershipSignificant differencesCharge of hospitalizationRoutine home dischargeHeart failure hospitalizationMean lengthNational Inpatient SampleCost of hospitalizationHF hospitalizationFailure hospitalizationHome dischargeHospital dischargeMale patientsInpatient SamplePrimary diagnosisProfit hospitalsHospitalizationMedian costMedian chargeMortality rateHospital
2013
Standard care versus protocol based therapy for new onset Pseudomonas aeruginosa in cystic fibrosis
Mayer‐Hamblett N, Rosenfeld M, Treggiari MM, Konstan MW, Retsch‐Bogart G, Morgan W, Wagener J, Gibson RL, Khan U, Emerson J, Thompson V, Elkin EP, Ramsey BW, for the EPIC E. Standard care versus protocol based therapy for new onset Pseudomonas aeruginosa in cystic fibrosis. Pediatric Pulmonology 2013, 48: 943-953. PMID: 23818295, PMCID: PMC4059359, DOI: 10.1002/ppul.22693.Peer-Reviewed Original ResearchConceptsTobramycin inhalation solutionHistorical controlsCystic fibrosisTrial participantsCulture positivityPA recurrenceDifferent antibiotic regimensHistorical control cohortInitial eradication therapyIncidence of hospitalizationStandard of careAntibiotic regimensEradication therapyRespiratory symptomsStandard careHospitalization outcomesHospitalization ratesCare treatmentControl cohortInhalation solutionAntimicrobial therapyClinical trialsEpidemiologic studiesInfection controlEligibility criteriaAssociation of Single- vs Dual-Chamber ICDs With Mortality, Readmissions, and Complications Among Patients Receiving an ICD for Primary Prevention
Peterson PN, Varosy PD, Heidenreich PA, Wang Y, Dewland TA, Curtis JP, Go AS, Greenlee RT, Magid DJ, Normand SL, Masoudi FA. Association of Single- vs Dual-Chamber ICDs With Mortality, Readmissions, and Complications Among Patients Receiving an ICD for Primary Prevention. JAMA 2013, 309: 2025-2034. PMID: 23677314, PMCID: PMC3752924, DOI: 10.1001/jama.2013.4982.Peer-Reviewed Original ResearchConceptsDual-chamber ICDSingle-chamber devicesDevice-related complicationsPrimary preventionDual-chamber devicesICD RegistryNational Cardiovascular Data Registry ICD RegistryPropensity-matched cohortRetrospective cohort studyHeart failure readmissionRate of complicationsSudden cardiac deathMedicaid Services feePropensity-score matchingCause hospitalizationCause readmissionCohort studyHospital factorsCardiac deathHeart failureHospitalization outcomesRandomized trialsChamber ICDMAIN OUTCOMEHigh risk
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply